Danaher Corp. (DHR): Rasio rega marang prakiraan pendapatan
Strong pricing power in biomedicine guarantees Danaher Corp. (DHR) a steady cash flow. The projected P/S multiple confirms this correlation, where 4.20 is recorded as the baseline value. The holding's robust liquidity relies on regular sales of consumables. Meanwhile, the business maintains resilience during recessions due to its diagnostic profile, ignoring economic downturns.
Rincian analitis perusahaan danaher.com (DHR)
- rega saham lan target rega konsensus:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Rasio Total Utang marang Ekuitas Danaher Corp.|DHR - Rasio silihan jangka dawa marang modal|Utang jangka cendhak marang ekuitas Danaher Corporation|DHR - Gunggung kewajiban utang perusahaan|Utang-utang marang kapitalisasi buku Danaher Corp|DHR - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Danaher|Likuiditas cepet danaher.com
- rincian asil keuangan lan kelipatan valuasi:
DHR - Bathi perusahaan|Proyeksi bathi mangsa ngarep Danaher Corp.|DHR - Pangali P/E|Pangali Forward P/E Danaher Corp.|DHR - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Danaher Corporation Inc.|DHR - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Danaher|DHR - Bathi saben saham sajroning taun lumaku|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan danaher.com|DHR - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Danaher Corp.
- rincian pendapatan lan dodolan:
Analisis komprehensif perusahaan:Danaher Corp. DHR
The efficiency of the DBS system and the capital allocation expertise of Danaher Corp. (DHR) ensure high cash flow predictability. By analyzing the forward price-to-sales chart, an investor can track the daily market value of every dollar of expected revenue, which eliminates the lags between quarterly reports. This indicator allows for the comparison of current quotes with projected sales, identifying risks of asset overvaluation during periods of volatility.
Analisis pesaing Danaher Corp.
Rasio rega marang prakiraan pendapatan Intuitive Surgical Inc ISRG|Multiplikator Forward P/S Becton Dickinson & Company BDX|STE - Rasio rega marang prakiraan pendapatan|West Pharmaceutical Services (WST) - Multiplikator forward rega marang pendapatan|BAX: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Masimo|STVN (stevanatogroup.com) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan TFX (Teleflex Incorporated)|Rasio rega marang prakiraan pendapatan Merit Medical (MMSI)|Envista - Kapitalisasi marang prakiraan pendapatan|ICU Medical, Inc. - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake XRAY (Dentsply Sirona Inc)|LMAT - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake AtriCure Corp ATRC|staar.com (STAA) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan ChromaDex Corporation|ZIMV (ZimVie Inc) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan ANGO (AngioDynamics)|Rasio rega marang prakiraan pendapatan Cerus Corp (CERS)|TKNO: Rega mangsa ngarep marang pendapatan|Rasio rega marang prakiraan pendapatan Monogram Technologies Inc. MGRM|Rega forward marang dodolan STSS|INFU - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan UTMD (Utah Medical Products Inc.)|KORU Medical Systems Inc. (KRMD) - Rasio rega marang prakiraan pendapatan|Nyxoah S.A. - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Microbot Medical, Inc.|Kapitalisasi marang prakiraan pendapatan PDEX (Pro-Dex)|Rasio rega marang prakiraan pendapatan Zentek (ZTEK)|Rasio kapitalisasi marang dodolan sing dikarepake Elutia Inc|Multiplikator Forward P/S MLSS (milestonescientific.com)|NXGL: Kapitalisasi marang prakiraan pendapatan|Retractable Tech - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Harvard Bioscience Inc. HBIO|FEMY: Multiplikator Forward P/S|MeihuaMed - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Predictive Oncology Inc|callanjmb.com (CJMB) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Atrion Corporation (ATRI)|Rasio kapitalisasi marang dodolan sing dikarepake neurometrix.com
